Monitoring ctDNA may help identify patients with limited-stage small cell lung cancer who are likely to benefit from consolidation immunotherapy and those who can skip it.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/can-ctdna-guide-immunotherapy-limited-stage-sclc-2025a1000p84?src=rss
Author :
Publish date : 2025-09-22 20:03:00
Copyright for syndicated content belongs to the linked Source.